United Kingdom Clinical Negligence Market Data Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "UK Clinical Negligence Market 2021- Market Data Report" report has been added to ResearchAndMarkets.com's offering.

Across the UK, the publisher estimates that £3.5 billion was paid out in CN cases in 2020/21, most of this by public sector health bodies, via the main public indemnity organisations or directly by departments for health and public health organisations.

In 2020/21, they estimate law firms earned revenue of over £1.0 billion from CN cases. This represents little change on the level of legal fees for 2019/20, because of the impact of COVID-19 on cases handled.

There remains a large pipeline of future cases to be handled, with state backed indemnity organisations, medical defence organisation, private sector healthcare providers and insurers, probably holding around £150 billion in provisions and contingent liabilities to cover potential future CN payments.

Key Topics Covered:

EXECUTIVE SUMMARY

• Around £3.5 billion spent annually on CN cases
• Law firms earn over £1bn annually from CN cases
• With case numbers down in 2020 because of COVID
• But a substantial case load going forward
• Four key participants for a market in two halves
• Key recent developments and market drivers

INTRODUCTION

• Two types of damage payments
• Lump sum payment and the PIDR
• Abbreviations

MARKET STRUCTURE

• Four main market participants
• It's a market in two halves
• Clinical negligence indemnity/insurance cover
• Individual indemnity and insurance cover is still required
• The Clinical Negligence protocol

MARKET DRIVERS

• Coronavirus
• The Coronavirus Act 2020 - Clinical Negligence Scheme for Coronavirus (CNSC)
• Medical Defence Organisations also widen their cover
• COVID-19 may increase future risks
• COVID-19 leads to changes in how CN cases are handled and investigated
• New NHS Resolution Business Plan
• Average awards continue to increase
• Obstetrics, the main cause of claims inflation
• Number of CN cases going through the courts declines
• Health grounds defence may be removed

THE KEY PLAYERS

• Overview
• Indemnity Organisations
• Other medical malpractice insurance and indemnity providers
• Claimant and defendant legal advice - two separate market segments
• Selected Law Firm Profiles
• A small selection of law firms involved in CN cases are profiled below.

MARKET SIZE AND TRENDS

• COVID-19 cuts new case numbers in 2020
• Public Indemnity Organisations account for the bulk of cases
• Around 30% of CN payment present legal fees
• Clinical negligence legal revenue

THE FUTURE

• Potential reform of the process of handling lower value CN claims
• Potential introduction of fixed Recoverable costs
• Changes to the Guideline Hourly Rate
• The Commons Health and Social Care Committee calls for changes in the CN process
• Potential expenditures in the pipeline

ASSOCIATIONS

For more information about this report visit https://www.researchandmarkets.com/r/cxwarp